Immunology and Microbiology
Hepatitis C Virus
100%
Human Immunodeficiency Virus 1
64%
Hepatitis C
46%
Neutralizing Antibody
36%
Human Immunodeficiency Virus
33%
Viremia
25%
Blood Plasma
23%
Epitope
21%
T Cell
20%
T-Helper Cell
19%
Neutralization
15%
Viral Clearance
12%
Viral Load
12%
Antibody Response
12%
Viral Envelope
12%
Drug Resistance
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Phylogeny
9%
Monospecific Antibody
9%
Hypervariable Region
8%
Virus Quasispecies
8%
Vaccine Efficacy
8%
Monoclonal Antibody
7%
Glycoprotein
7%
Quasispecies
6%
Reverse Transcriptase
6%
Cytotoxic T-Cell
6%
Convergent Evolution
6%
Humoral Immunity
6%
Seroconversion
6%
Genetic Distance
5%
Viral Replication
5%
Titer
5%
Genetic Variability
5%
Keyphrases
Hepatitis C Virus
52%
Human Immunodeficiency Virus Type 1 (HIV-1)
31%
Hepatitis C Virus Infection
19%
Virus
16%
Hepatitis C
13%
AIDS/HIV
12%
Antiretroviral Therapy
11%
Broadly Neutralizing Antibodies
11%
Viremia
11%
Neutralizing Antibodies
10%
Epitope
7%
Latent Reservoir
7%
Hepatitis C Virus Clearance
7%
Virus Envelope
7%
Viral Persistence
7%
Hepatitis C Virus RNA
6%
Acute Infection
6%
COVID-19
6%
Baltimore
6%
People Who Inject Drugs
6%
Resting CD4+ T Cells
6%
Viral
5%
CD4+ T
5%
Highly Active Antiretroviral Therapy (HAART)
5%
Medicine and Dentistry
Hepatitis C Virus
17%
Human Immunodeficiency Virus
16%
Hepatitis C
13%
Infection
8%
Drug Resistance
6%
COVID-19
6%
Disease
6%
Human Immunodeficiency Virus 1
6%
Highly Active Antiretroviral Therapy
6%
Viremia
6%
Severe Acute Respiratory Syndrome Coronavirus 2
5%
